High Mobility Group Box 1 Influences HSV1716 Spread and Acts as an Adjuvant to Chemotherapy

Viruses - Switzerland
doi 10.3390/v10030132
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Serum High-Mobility Group Box-1 Protein as a Specific Marker of Severe Abdominal Injury

Critical Care
Critical CareIntensive Care Medicine
2009English

High Mobility Group Box-1: A Missing Link Between Diabetes and Its Complications

Mediators of Inflammation
ImmunologyCell Biology
2016English

High-Mobility Group Box 1 Contributes to Lethality of Endotoxemia in Heme Oxygenase-1–Deficient Mice

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2009English

High-Mobility Group Box 1 Protein (HMGB1) Neutralization Ameliorates Experimental Autoimmune Encephalomyelitis

Journal of Autoimmunity
AllergyImmunology
2013English

Anti-High Mobility Group Box-1 Antibody Therapy for Traumatic Brain Injury

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2014English

Naturally Acquired Anti-High Mobility Group Box 1 Antibodies During Septic Shock

Critical Care
Critical CareIntensive Care Medicine
2009English

High Mobility Group Box 1 Levels in on and Off-Pump Cardiac Surgery Patients

International Heart Journal
MedicineCardiovascular MedicineCardiology
2011English

Targeting High Mobility Group Box-1 (HMGB1) Promotes Cell Death in Myelodysplastic Syndrome

Clinical Cancer Research
Cancer ResearchOncology
2019English

Urinary High-Mobility Group Box-1 Associates Specifically With Lupus Nephritis Class V

Lupus
Rheumatology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy